282 related articles for article (PubMed ID: 29681578)
1. Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.
Terasaki F; Fujita SI; Kanzaki Y; Hirose Y; Ishizaka N
Int Heart J; 2018 May; 59(3):647-651. PubMed ID: 29681578
[TBL] [Abstract][Full Text] [Related]
2. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
Smedema JP; White L; Klopper AJ
Cardiovasc J Afr; 2008; 19(6):309-10. PubMed ID: 19104727
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
[TBL] [Abstract][Full Text] [Related]
5. Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.
Maeda D; Kanzaki Y; Fujita S; Inuyama M; Takashima S; Miyamura M; Terasaki F; Hoshiga M
ESC Heart Fail; 2019 Aug; 6(4):889-893. PubMed ID: 31264810
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
Danwade TA; Devidutta S; Shelke AB; Saggu DK; Yalagudri SD; Sridevi C; Reddy NK; Narasimhan C
Heart Rhythm; 2018 Feb; 15(2):234-239. PubMed ID: 29061522
[TBL] [Abstract][Full Text] [Related]
7. Novel ECG parameters are strongly associated with inflammatory
Sipilä K; Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K
Int J Cardiol; 2017 Dec; 249():454-460. PubMed ID: 29121750
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic Cardiomyopathy Complicated by Cardiac Sarcoidosis Diagnosed by Both the Morphological Abnormalities and the Time Course of the Disease.
Miki Y; Nakamura K; Sasaki T; Goto K; Take Y; Naito S
Int Heart J; 2021 Jan; 62(1):201-206. PubMed ID: 33455993
[TBL] [Abstract][Full Text] [Related]
9. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
10. Failure of follow-up gallium single-photon emission computed tomography and fluorine-18-fluorodeoxyglucose positron emission tomography to predict the deterioration of a patient with cardiac sarcoidosis.
Kaku B; Kanaya H; Horita Y; Uno Y; Yamazaki T; Fujita T; Ohka T
Circ J; 2004 Aug; 68(8):802-5. PubMed ID: 15277743
[TBL] [Abstract][Full Text] [Related]
11. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
[TBL] [Abstract][Full Text] [Related]
12. Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography.
Ohira H; Tsujino I; Sato T; Yoshinaga K; Manabe O; Oyama N; Nishimura M
Intern Med; 2011; 50(11):1207-9. PubMed ID: 21628936
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Higuchi Y; Kimoto Y; Tanoue R; Tokunou T; Tomonari K; Maeda T; Horiuchi T
Intern Med; 2018 Jun; 57(11):1601-1604. PubMed ID: 29321427
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
15. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
19. A 52-Year-Old Man With Unheralded Syncope.
Wadhera RK; Stewart GC; O'Gara PT
JAMA Cardiol; 2017 Dec; 2(12):1394-1395. PubMed ID: 29049514
[No Abstract] [Full Text] [Related]
20. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
